PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.38%
Revenue growth under 50% of ACB.TO's 33.24%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
44.31%
Gross profit growth 1.25-1.5x ACB.TO's 32.16%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
143.07%
EBIT growth 1.25-1.5x ACB.TO's 123.25%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
143.07%
Operating income growth above 1.5x ACB.TO's 22.93%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-154.14%
Negative net income growth while ACB.TO stands at 105.27%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-148.34%
Negative EPS growth while ACB.TO is at 104.43%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-145.86%
Negative diluted EPS growth while ACB.TO is at 104.43%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
23.88%
Share count expansion well above ACB.TO's 18.67%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
23.19%
Diluted share count expanding well above ACB.TO's 18.67%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-100.98%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-48.44%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
82.29%
Positive long-term OCF/share growth while ACB.TO is negative. John Neff would see a structural advantage in sustained cash generation.
82.29%
Positive OCF/share growth while ACB.TO is negative. John Neff might see a comparative advantage in operational cash viability.
87.74%
Positive 3Y OCF/share CAGR while ACB.TO is negative. John Neff might see a big short-term edge in operational efficiency.
-240.94%
Negative 10Y net income/share CAGR while ACB.TO is at 238.70%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-240.94%
Negative 5Y net income/share CAGR while ACB.TO is 117.22%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
6.64%
Below 50% of ACB.TO's 107.77%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
1674.77%
10Y equity/share CAGR above 1.5x ACB.TO's 335.43%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
1674.77%
5Y equity/share CAGR above 1.5x ACB.TO's 546.42%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
3789.23%
3Y equity/share CAGR above 1.5x ACB.TO's 1338.59%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.85%
Our AR growth while ACB.TO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
43.35%
Inventory growth well above ACB.TO's 52.03%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
52.48%
Asset growth at 50-75% of ACB.TO's 100.64%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
14.24%
Under 50% of ACB.TO's 82.02%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
272.38%
We have some new debt while ACB.TO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-50.01%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-24.57%
We cut SG&A while ACB.TO invests at 13.63%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.